- Medicine - 11:00 Genes for a longer, healthier life found
- Life Sciences - 06:02 Brain tumour research appeal: what will you give this Christmas?
- Medicine - Nov 30 Penn Senior Amanda Cornfield Takes to Medical Research and Ultimate Sport
- Medicine - Nov 30 New free online service to help people use hearing aids
- Medicine - Nov 30 Yale launches new Center for Health & Learning Games
- Medicine - Nov 30 Why are many of the most vulnerable Californians rejecting managed health care?
- Medicine - Nov 30 $6 million grant will help UCLA- USC team develop kid- friendly technology to predict asthma attacks
- Administration - Nov 30 GP funding disadvantages patients in deprived areas
- Medicine - Nov 30 Novartis highlights clinical advances at ASH 2015, underscoring leadership in hematology research
- Computer Science - Nov 30 The truth about mobile phone and wireless radiation: what we know, what we need to find out, and what you can do now
- Medicine - Nov 27 Specific diet works to help epilepsy
- Medicine - Nov 27 Researchers tackle spread of pancreatic cancer
- Medicine - Nov 27 Bristol postgraduates reap research rewards
- Social Sciences - Nov 27 Comment: Thatcher helped people to buy their own homes – but the poorest paid the price
- Medicine - Nov 27 Research centre marks a new era for child health in Queensland
- Medicine - Nov 26 The health toll on female migrant workers in Gulf countries
Stopping cell migration may help block fibrosis and the spread of cancer
Discoveries by a Yale-led team of scientists could lead the way for development of new therapies for treating fibrosis and tumor metastasis. The researchers have both uncovered a signaling pathway that promotes cell migration in certain forms of pulmonary fibrosis, a deadly lung disease, and developed a drug treatment that may block the cancer cell migration. The study appears in the Advance Online Publication of Nature Cell Biology.
Pulmonary fibrosis is the development of excessive connective tissue in the lungs. It can develop without a known cause, and produces permanent scar tissue in the lungs. There is no known cure or treatment to slow down its progress.
Cell migration is the biological process by which cells move around the body, often contributing to the development or spread of diseases such as fibrosis or metastatic cancer.
Fibroblast connective tissue cells and cancer cells migrate in a way that requires sustained activation of signaling pathways. But until now the regulation of these cellular functions has been poorly understood. The Yale team studied the workings of a stimulant of cell migration known as lysophosphatidic acid (LPA). They identified the chemical reactions that ultimately induce cell migration, but more importantly, discovered a way to block the pathway via inhibition of the proteins responsible for promoting the migration.
Senior author Dianqing (Dan) Wu, professor of pharmacology and vascular biology at Yale School of Medicine and member of Yale Cancer Center, explained, "Our ability to block the pathway provides a potential therapeutic target for treating pulmonary fibrosis, a very serious disease that lacks effective treatments, and other types of fibrosis. Because cancer cells, particularly melanoma and lung cancer cells containing activated BRAF genetic mutations, can use this signaling pathway to migrate, blocking this pathway could also prevent metastasis of these cancers."
Other authors are Xiaoqing Gan, Jiyong Wang and Chen Wang of Yale; Eeva Sommer and Dario Alessi of the University of Dundee; Tohru Kozasa of the University of Illinois at Chicago; Srinivasa Srinivasula of the National Cancer Institute; Stefan Offermanns of the Max-Planck-Institute for Heart and Lung Research; and Melvin I. Simon of the University of California at San Diego.
Last job offers
- Business/Economics - 27.11
Doktoranden im Bereich Banking
- Medicine/Pharmacology - 27.11
Dozentin / Dozent für Medizinproduktentwicklung (80-100%)
- Earth Sciences - 26.11
Doktorandin / Doktoranden in der Fachgruppe Gebirgswald, Naturgefahren und GIS
- Physics/Materials Science - 25.11
Physiker Optikentwicklung Optoelektronische Messgeräte
- Medicine/Pharmacology - 25.11
Un poste de professeur-e HES « Santé communautaire / santé publique » Taux d’activité : 100%
- Life Sciences - 25.11
Assistant professor in Evolutionary Genetics
- Social Sciences - 30.11
Professor in Social Environmental Studies (PER 2015/401)
- Medicine/Pharmacology - 27.11
Assistant professor in Ergonomics, psycosocial work environment
- Mechanical Engineering - 26.11
- Mechanical Engineering - 24.11
- Chemistry - 30.11
Professur "Analytische Chemie - Chemoinformatik / Chemometrik"
- History/Archeology - 30.11
Juniorprofessur für Public History (JP 246)
- Medicine/Pharmacology - 30.11
Director of the Nihr Wessex Clahrc and Professor of Applied Health Services Research
- Law/Forensics - 30.11
Associate Professorship of Property Law
- Medicine/Pharmacology - 1.12
Associate/Full Professor - BPS
- Psychology - 30.11